S&P/ASX 200 (INDEXASX: XJO)

It was another strong week for global markets with the ASX 200 rising 1.7% and the Dow Jones ending up 3.3% last week, as reporting season continued.

It seems to me that global markets are stuck in a trading pattern, oscillating between euphoria when signs of a vaccine are announced, to despair as new economic results and increasingly protectionist policies are released around the world.

It seems to me that global markets are stuck in a trading pattern, oscillating between euphoria when signs of a vaccine are announced, to despair as new economic results and increasingly protectionist policies are released around the world.

Overnight in the US, global share markets recovered on the back of an improving crude oil price, now $32 per barrel, and an uptick in airline bookings, sending both sectors up 4% in the US.

Here’s the Financial Planning news you need to know. Overnight, global share markets recovered on the back of an improving crude oil price, now $32 per barrel, and an uptick in airline bookings, sending both sectors up 4% in the US.

The S&P/ASX 200 (ASX:XJO) is expected to open lower on Wednesday following weak leads from Wall Street.

As we wrote here yesterday, the announcement of some success with Moderna’s COVID-19 trials was a case of too much too soon, with most global markets giving back gains as the results were questioned.

A covid cure on the horizon? US-based drugmaker Moderna revealed positive results from its human trials of a Coronavirus vaccine, treating those yet to suffer from the disease with some positive results.

Overnight, US drugmaker Moderna announced positive results from its human trials of a COVID-19 vaccine, treating those yet to suffer from the disease with some positive results.

The ASX 200 (ASX: XJO) is set to open higher, China and Australia trade tensions to ease, Xero reports and more.